In another study, the beneficial effects of a genetically modified Bifidobacterium bifidum strain to produce antioxidant enzymes (SOD and CAT) were also observed in cellular colitis models, specifically in the HT-29 cell line, through the regulation of inflammatory cytokines [16]. The gene discussed is CAT; the disease is colitis.